Gateway Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$545K Buy
+8,986
New +$524K 0.02% 553
2024
Q2
Sell
-3,854
Closed -$209K 266
2024
Q1
$209K Sell
3,854
-680
-15% -$34.6K 0.08% 226
2023
Q4
$233K Buy
4,534
+535
+13% +$28.1K 0.09% 191
2023
Q3
$232K Sell
3,999
-57
-1% -$3.49K 0.04% 228
2023
Q2
$259K Buy
+4,056
New +$272K 0.05% 199

Other funds holding BMY

Gateway Wealth Partners's BMY Position: Q1 2026 in Review

Gateway Wealth Partners opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 8,986 shares worth $545K. The stake represents 0.02% of the portfolio and ranks #553 among its holdings. This is a return to the name: Gateway Wealth Partners previously reported a position in BMY as recently as Q1 2024.

Gateway Wealth Partners first reported a position in BMY in Q2 2023 and has held it in 5 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Gateway Wealth Partners held 8,986 shares of Bristol-Myers Squibb worth $545K as of Q1 2026.
  • Bristol-Myers Squibb was a new Gateway Wealth Partners position in Q1 2026.
  • Bristol-Myers Squibb made up 0.02% of Gateway Wealth Partners's portfolio in Q1 2026, its #553 holding.
  • Gateway Wealth Partners first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 5 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Gateway Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.